文献速递青光眼

穿透性黏小管成形术治疗原发性闭角型青光眼的初步疗效

[Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2019-01-01

前瞻性病例系列研究纳入22例(24只眼)原发性闭角型青光眼患者,在温州医科大学附属眼视光医院接受穿透性黏小管成形术,4只眼因Schlemm管未完成360°穿通改行小梁切除术,最终19例(20只眼)完成手术并分析。术后6个月条件成功率为95%(19/20)、完全成功率为90%(18/20),术后眼压和用药数量较术前均显著下降(均P<0.01),35%患眼出现手术并发症。结论认为该手术安全且短期降眼压有效,但需更长期随访。

要点

  • 术后6个月条件成功率95%(19/20),完全成功率90%(18/20)。
  • 术前眼压(38.0±11.9)mmHg,术后6个月降至(15.4±3.7)mmHg(P<0.01)。
  • 20只眼中7只(35%)出现并发症,8只(40%)术后3个月内出现一过性高眼压。

核心结论

  • 初步研究表明穿透性黏小管成形术治疗原发性闭角型青光眼安全且短期降眼压有效,但需要更长期随访。

研究设计与样本

  • 前瞻性介入性病例系列研究,2015年6月至2018年8月在温州医科大学附属眼视光医院纳入22例(24只眼)原发性闭角型青光眼患者接受穿透性黏小管成形术。
  • 4只眼因Schlemm管未完成360°穿通改行小梁切除术,最终对19例(20只眼)完成手术者进行分析,其中男11例、女8例,年龄(54±7)岁(41~65岁)。
  • 术后随访时间为1天、7天、1个月、3个月和6个月,统计采用单因素重复测量方差分析及秩和检验。

主要发现

  • 术前眼压(38.0±11.9)mmHg,术后1天、7天、1个月、3个月和6个月眼压分别为(14.5±11.1)、(16.1±6.0)、(17.7±5.5)、(15.7±5.0)和(15.4±3.7)mmHg,术后与术前比较差异均有统计学意义(均P<0.01)。
  • 术前抗青光眼用药数量中位数为3(2~5)种,术后5个时间点用药数量中位数(范围)分别为0(0~3)、0(0~2)、0(0~3)、0(0~2)、0(0~2)种,术后与术前比较差异均有统计学意义(均P<0.01)。
  • 术后6个月条件成功率为95%(19/20),完全成功率为90%(18/20)。
  • 20只患眼中7只(35%)出现手术并发症,包括前房积血3只眼(15%)、浅前房2只眼(10%)、角膜后弹力层脱离1只眼(5%)、滤过内口堵塞1只眼(5%);8只眼(40%)在术后3个月内出现一过性高眼压。
  • 裂隙灯和超声生物显微镜检查显示14只眼(70%)未见明显滤过泡。

关键数值与推荐

  • 手术条件成功定义为使用降眼压药物情况下眼压≤21 mmHg(1 mmHg=0.133 kPa),完全成功定义为未使用任何降眼压药物情况下眼压≤21 mmHg。
  • 术前房角关闭范围为326.3°±46.6°。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出长期疗效仍有待进一步观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the preliminary efficacy and safety of penetrating canaloplasty for treating primary angle-closure glaucoma (PACG). Methods: It is a prospective interventional case series study. Twenty-two patients (24 eyes) with PACG were treated with penetrating canaloplasty (video attached) at the Eye Hospital of Wenzhou Medical University from June 2015 to August 2018. This modified canaloplasty was performed by making a window at the corneal-scleral bed. Aqueous was redirected to the opening of Schlemm's canal after the canaloplasty with intension sutures. Postoperative follow-up was made at 1 day, 7 days, 1 month, 3 months, and 6 months. Surgical success was defined as intraocular pressure (IOP) ≤ 21 mmHg (1 mmHg=0.133 kPa) with glaucoma medication (quantified success) and without any glaucoma medication (complete success). Main outcome measures included IOP, number of medication, surgical success rate, complications, and filtering bleb status. One-way repeated measure ANOVA and rank sum test were used in statistical analysis. Results: Due to the failure of circumferential catheterization of the canal, 4 eyes converted to trabeculectomy. A total of 19 PACG patients (20 eyes) achieved the successful 360-degree catheterization of the canal, including 11 males and 8 females. The mean age was (54±7) years old (range: 41-65 years old), and the mean angle-closure range was (326.3±46.6) degrees. The mean preoperative IOP was (38.0±11.9) mmHg with the median medication number of 3 (range: 2-5). The mean postoperative IOP was (14.5±11.1), (16.1±6.0), (17.7±5.5), (15.7±5.0), and (15.4±3.7) mmHg at 1 day, 7 days, 1 month, 3 months, and 6 months, respectively. There was significant difference in IOP between postoperative and preoperative (all P<0.01). The median medication number (range) was 0 (0-3), 0 (0-2), 0(0-3), 0(0-2), and 0 (0-2) at the 5 time points, respectively. There was significant difference in medication number between postoperative and preoperative (all P<0.01). The quantified success rate was 95%(19/20), and the complete success rate was 90%(18/20) at 6 months. Postoperative complications were observed in 7 eyes (35%) of 20 PACG eyes, including 3 eyes (15%) with hyphema, 2 eyes (10%) with shallow anterior chamber, 1 eye (5%) with Descemet membrane detachment, and 1 eye (5%) with filtration obstruction at the trabeculum ostium. According to the results of slit lamp and ultrasound biomicroscopy examinations, 70% of the eyes (14/20) had no filtering bleb. Eight eyes (40%) with IOP spike were observed. Conclusion: Preliminary study shows penetrating canaloplasty is safe and effective in the treatment of PACG, but needs a longer follow-up. (Chin J Ophthalmol, 2019, 55: 448-453). 目的: 观察穿透性黏小管成形术治疗原发性闭角型青光眼(PACG)的短期疗效及其安全性。 方法: 前瞻性病例系列研究。2015年6月至2018年8月选取22例(24只眼)PACG患者于温州医科大学附属眼视光医院接受穿透性黏小管成形术治疗(附手术视频),手术在常规Schlemm管成形术后于角巩膜缘床开窗进入前房,使房水可以直接经巩膜瓣下进入Schlemm管断段开口,术中紧密缝合巩膜瓣,术后进行1 d、1周、1个月、3个月、6个月随访。手术成功定义为术后眼压≤21 mmHg(1 mmHg=0.133 kPa);使用降眼压药物情况下眼压≤21 mmHg为条件成功,未使用任何降眼压药物眼压≤21 mmHg为完全成功。主要观察的效应指标包括眼压、降眼压药物数量、手术成功率、手术并发症及术后滤过泡状态。统计学分析采用单因素重复测量方差分析及秩和检验。 结果: 22例(24只眼)PACG患者中4只眼由于Schlemm管未完成360°穿通而改行小梁切除术,最终纳入19例(20只眼)完成穿透性黏小管成形术的患者进行统计分析。男、女比例为11∶8,年龄为(54±7)岁(41~65岁),房角关闭范围为326.3°±46.6°。术前眼压为(38.0±11.9)mmHg,术后第1天、1周、1个月、3个月和6个月的眼压分别为(14.5±11.1)、(16.1±6.0)、(17.7±5.5)、(15.7±5.0)和(15.4±3.7)mmHg,术后与术前比较差异均有统计学意义(均P<0.01)。术前抗青光眼用药数量的中位数(范围)为3(2~5)种,术后第1天、1周、1个月、3个月及6个月抗青光眼用药数量分别为0(0~3)种、0(0~2)种、0(0~3)种、0(0~ 2)种、0(0~2)种,术后与术前比较差异均有统计学意义(均P<0.01)。术后6个月手术条件成功率和完全成功率分别为95%(19/20)和90%(18/20)。20只PACG患眼中7只患眼(35%)出现手术并发症,包括前房积血3只眼(15%)、浅前房2只眼(10%)、角膜后弹力层脱离1只眼(5%)、滤过内口堵塞1只眼(5%)。眼前段裂隙灯照相和超声生物显微镜检查显示14只眼(70%)未见明显滤过泡。8只眼(40%)在术后3个月内出现一过性高眼压现象。 结论: 穿透性黏小管成形术是治疗PACG的安全手术方式,并具有显著的短期降眼压疗效,其长期疗效仍有待进一步观察。(中华眼科杂志,2019,55:448-453).

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cheng HH, Hu C, Meng JY, et al. [Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma]. Zhonghua Yan Ke Za Zhi. 2019. PMID: 31189275. doi:10.3760/cma.j.issn.0412-4081.2019.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。